文献速递其他结缔组织病

血清球蛋白间隙升高可高度可靠地提示系统性风湿病患者红细胞沉降率升高

Elevated serum globulin gap as a highly reliable marker of elevated erythrocyte sedimentation rate in patients with systemic rheumatic diseases.
PubMed 文献 · Semin Arthritis Rheum · 2019-05-11

本研究回顾性分析系统性风湿病患者的电子病历,发现血清球蛋白间隙与白球比(A:G)均与CRP和ESR相关(p<0.001),且对ESR的相关性更强。球蛋白间隙≥4.0 g/dl和A:G比值<0.8对ESR升高的阳性预测值均≥0.960,球蛋白间隙高者其随时间变化可反映ESR变化。

要点

  • 球蛋白间隙≥4.0 g/dl对ESR升高的阳性预测值≥0.960。
  • A:G比值<0.8对ESR升高的阳性预测值≥0.960。
  • 球蛋白间隙变化可反映ESR变化,或可减少ESR检测需求。

核心结论

  • 在球蛋白间隙升高的系统性风湿病患者中,ESR几乎总是升高,或可减少ESR检测而不影响诊疗质量。

研究设计与样本

  • 回顾性分析单中心学术医学中心风湿科门诊2015年5月至2017年6月系统性风湿病患者的电子病历。
  • 两个独立队列:发现队列263例受试者446条记录;验证队列438例受试者1959条记录。

主要发现

  • 球蛋白间隙和A:G比值与CRP水平及ESR相关(p<0.001),与ESR的相关系数大于与CRP的相关系数。
  • ROC曲线分析显示ESR的曲线下面积优于CRP。
  • 球蛋白间隙升高(≥4.0 g/dl)和A:G比值低(<0.8)的记录比例分别约为8.4%和2.6%。
  • 球蛋白间隙升高和A:G比值低对ESR升高的阳性预测值均≥0.960。
  • 球蛋白间隙高的患者中,球蛋白间隙随时间的变化忠实反映ESR的变化。

关键数值与推荐

  • 球蛋白间隙升高定义为≥4.0 g/dl,A:G比值低定义为<0.8。
  • 球蛋白间隙升高和A:G比值低对ESR升高的阳性预测值均≥0.960。

临床怎么用

  • 对于球蛋白间隙升高的系统性风湿病患者,ESR几乎总是升高,可考虑减少ESR检测以节约成本。

局限性

  • 本研究为单中心回顾性研究,结论需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Serum C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR) are the two most commonly used markers of inflammation in clinical practice. Reducing the need for these tests could lead to considerable cost savings without sacrificing the quality of patient care. METHODS: The electronic medical records of patients with systemic rheumatic diseases seen between May 2015 and June 2017 in the rheumatology clinics at a single academic medical center were retrospectively reviewed. Correlations and receiver operator characteristic (ROC) curves between serum CRP level and ESR vs serum globulin gap (the difference between levels of total protein and albumin) and albumin-to-globulin (A:G) ratio were determined. RESULTS: In two independent cohorts (discovery: 263 subjects, 446 entries; validation: 438 subjects, 1959 entries), the globulin gap and A:G ratio correlated (p < 0.001) with CRP level and ESR, with correlation coefficients being greater for ESR than for CRP level. ROC curve analyses demonstrated better area-under-curve for ESR than for CRP level. The percentages of entries with elevated globulin gap (≥4.0 g/dl) and low A:G ratio (<0.8) were ∼8.4% and ∼2.6%, respectively, and each had a positive predictive value of ≥0.960 for elevated ESR. Among patients with high globulin gap, the change in globulin gap over time faithfully reflected changes in ESR. CONCLUSION: In the subset of systemic rheumatic disease patients who harbor an elevated globulin gap, the ESR is almost always elevated. This novel observation sets the conceptual foundation and rationale for subsequent prospective studies that assess whether ESR testing in this subset of rheumatic disease patients could be reduced without sacrificing patient care. Ultimately, ordering an ESR test may often be unnecessary, thereby resulting in cost savings.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Stohl W, Kenol B, Kelly AJ, et al. Elevated serum globulin gap as a highly reliable marker of elevated erythrocyte sedimentation rate in patients with systemic rheumatic diseases. Semin Arthritis Rheum. 2019. PMID: 31153707. doi:10.1016/j.semarthrit.2019.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。